Aardvark Therapeutics, Common Stock Market Value
| AARD Stock | 13.65 0.61 4.28% |
| Symbol | Aardvark |
Aardvark Therapeutics, Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aardvark Therapeutics,. If investors know Aardvark will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aardvark Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aardvark Therapeutics, is measured differently than its book value, which is the value of Aardvark that is recorded on the company's balance sheet. Investors also form their own opinion of Aardvark Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Aardvark Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aardvark Therapeutics,'s market value can be influenced by many factors that don't directly affect Aardvark Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aardvark Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Aardvark Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aardvark Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aardvark Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aardvark Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aardvark Therapeutics,.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Aardvark Therapeutics, on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Aardvark Therapeutics, Common or generate 0.0% return on investment in Aardvark Therapeutics, over 30 days. Aardvark Therapeutics, is related to or competes with Assembly Biosciences, Zura Bio, Nautilus Biotechnology, Caribou Biosciences, Enanta Pharmaceuticals, Tenaya Therapeutics, and Avalo Therapeutics. Aardvark Therapeutics, is entity of United States More
Aardvark Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aardvark Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aardvark Therapeutics, Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.16 | |||
| Information Ratio | 0.0433 | |||
| Maximum Drawdown | 36.39 | |||
| Value At Risk | (8.66) | |||
| Potential Upside | 9.35 |
Aardvark Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aardvark Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aardvark Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Aardvark Therapeutics, historical prices to predict the future Aardvark Therapeutics,'s volatility.| Risk Adjusted Performance | 0.0489 | |||
| Jensen Alpha | 0.1071 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.0517 | |||
| Treynor Ratio | 0.1095 |
Aardvark Therapeutics, Backtested Returns
At this point, Aardvark Therapeutics, is somewhat reliable. Aardvark Therapeutics, secures Sharpe Ratio (or Efficiency) of 0.0284, which signifies that the company had a 0.0284 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aardvark Therapeutics, Common, which you can use to evaluate the volatility of the firm. Please confirm Aardvark Therapeutics,'s Risk Adjusted Performance of 0.0489, downside deviation of 5.16, and Mean Deviation of 4.58 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%. Aardvark Therapeutics, has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 3.12, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aardvark Therapeutics, will likely underperform. Aardvark Therapeutics, right now shows a risk of 6.21%. Please confirm Aardvark Therapeutics, semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to decide if Aardvark Therapeutics, will be following its price patterns.
Auto-correlation | -0.27 |
Weak reverse predictability
Aardvark Therapeutics, Common has weak reverse predictability. Overlapping area represents the amount of predictability between Aardvark Therapeutics, time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aardvark Therapeutics, price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Aardvark Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.27 | |
| Spearman Rank Test | -0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Aardvark Therapeutics, lagged returns against current returns
Autocorrelation, which is Aardvark Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aardvark Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Aardvark Therapeutics, returns to help us make a trade decision. For example, suppose you find that Aardvark Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aardvark Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aardvark Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aardvark Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aardvark Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Aardvark Therapeutics, Lagged Returns
When evaluating Aardvark Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aardvark Therapeutics, stock have on its future price. Aardvark Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aardvark Therapeutics, autocorrelation shows the relationship between Aardvark Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Aardvark Therapeutics, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Aardvark Therapeutics, is a strong investment it is important to analyze Aardvark Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aardvark Therapeutics,'s future performance. For an informed investment choice regarding Aardvark Stock, refer to the following important reports:Check out Aardvark Therapeutics, Correlation, Aardvark Therapeutics, Volatility and Aardvark Therapeutics, Alpha and Beta module to complement your research on Aardvark Therapeutics,. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Aardvark Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.